16-66925016-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004165.3(RRAD):c.164C>T(p.Ala55Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000793 in 1,261,464 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A55S) has been classified as Likely benign.
Frequency
Consequence
NM_004165.3 missense
Scores
Clinical Significance
Conservation
Publications
- Brugada syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004165.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RRAD | TSL:1 MANE Select | c.164C>T | p.Ala55Val | missense | Exon 2 of 5 | ENSP00000299759.6 | P55042 | ||
| RRAD | c.164C>T | p.Ala55Val | missense | Exon 1 of 4 | ENSP00000559848.1 | ||||
| RRAD | c.164C>T | p.Ala55Val | missense | Exon 2 of 5 | ENSP00000559849.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.93e-7 AC: 1AN: 1261464Hom.: 0 Cov.: 30 AF XY: 0.00000161 AC XY: 1AN XY: 619324 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at